Xenon Pharmaceuticals IncNASDAQ:XENE
- LAST PRICE43.7300
- TODAY'S CHANGE (%)0.6000 (1.3911%)
- Bid / Lots35.0000/ 1
- Ask / Lots50.0000/ 1
- Open / Previous Close43.1400 / 43.1300
- Day Range
- 52 Week Range
- Volume536,095
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | XENE |
|---|---|---|
| 09:32 ET | 992 | 43.14 |
| 09:34 ET | 3500 | 42.76 |
| 09:36 ET | 1000 | 43.19 |
| 09:38 ET | 550 | 43.135 |
| 09:39 ET | 2358 | 42.935 |
| 09:41 ET | 2200 | 43.43 |
| 09:43 ET | 400 | 43.095 |
| 09:45 ET | 1200 | 43.23 |
| 09:48 ET | 5373 | 43.235 |
| 09:50 ET | 300 | 43.245 |
| 09:52 ET | 900 | 43.235 |
| 09:54 ET | 1606 | 43.235 |
| 09:56 ET | 200 | 43.235 |
| 09:57 ET | 1326 | 43.195 |
| 09:59 ET | 1500 | 43.195 |
| 10:01 ET | 300 | 43.195 |
| 10:06 ET | 3277 | 43.185 |
| 10:19 ET | 1400 | 43.295 |
| 10:21 ET | 500 | 43.245 |
| 10:26 ET | 600 | 43.135 |
| 10:32 ET | 254 | 43.153 |
| 10:33 ET | 738 | 43.39 |
| 10:35 ET | 1100 | 43.45 |
| 10:37 ET | 100 | 43.49 |
| 10:39 ET | 100 | 43.49 |
| 10:42 ET | 100 | 43.5 |
| 10:44 ET | 100 | 43.5 |
| 10:48 ET | 2010 | 43.655 |
| 10:50 ET | 755 | 43.31 |
| 10:51 ET | 800 | 43.24 |
| 10:53 ET | 7349 | 43.72 |
| 10:55 ET | 400 | 43.7 |
| 10:57 ET | 700 | 43.72 |
| 11:00 ET | 200 | 43.8 |
| 11:02 ET | 400 | 43.65 |
| 11:04 ET | 600 | 43.655 |
| 11:06 ET | 200 | 43.73 |
| 11:09 ET | 2702 | 43.6 |
| 11:20 ET | 495 | 43.57 |
| 11:24 ET | 100 | 43.56 |
| 11:27 ET | 31263 | 43.24 |
| 11:29 ET | 200 | 43.24 |
| 11:33 ET | 300 | 43.22 |
| 11:36 ET | 228 | 43.215 |
| 11:40 ET | 200 | 43.195 |
| 11:47 ET | 4100 | 43.195 |
| 11:51 ET | 4900 | 43.17 |
| 11:54 ET | 24725 | 43.34 |
| 11:58 ET | 300 | 43.245 |
| 12:07 ET | 1300 | 43.4 |
| 12:12 ET | 300 | 43.31 |
| 12:14 ET | 6600 | 43.31 |
| 12:16 ET | 100 | 43.31 |
| 12:18 ET | 100 | 43.44 |
| 12:20 ET | 505 | 43.29 |
| 12:21 ET | 100 | 43.27 |
| 12:23 ET | 200 | 43.21 |
| 12:39 ET | 5200 | 43.2325 |
| 12:43 ET | 377 | 43.16 |
| 12:45 ET | 200 | 43.16 |
| 12:50 ET | 100 | 43.075 |
| 12:56 ET | 200 | 43.175 |
| 01:03 ET | 600 | 43.09 |
| 01:06 ET | 600 | 43.03 |
| 01:14 ET | 100 | 43.085 |
| 01:15 ET | 200 | 43.08 |
| 01:17 ET | 300 | 43.01 |
| 01:19 ET | 1052 | 42.9093 |
| 01:21 ET | 5800 | 42.87 |
| 01:24 ET | 375 | 42.912 |
| 01:32 ET | 100 | 42.77 |
| 01:33 ET | 100 | 42.66 |
| 01:35 ET | 100 | 42.705 |
| 01:39 ET | 117 | 42.6512 |
| 01:46 ET | 272 | 42.71 |
| 01:48 ET | 4541 | 42.635 |
| 01:50 ET | 1206 | 42.81 |
| 01:51 ET | 300 | 42.69 |
| 02:08 ET | 1500 | 42.83 |
| 02:09 ET | 366 | 42.8 |
| 02:11 ET | 3991 | 42.99 |
| 02:15 ET | 100 | 43.02 |
| 02:18 ET | 100 | 43 |
| 02:22 ET | 500 | 43.1 |
| 02:31 ET | 900 | 43.21 |
| 02:33 ET | 189 | 43.2023 |
| 02:36 ET | 1000 | 43.21 |
| 02:44 ET | 2313 | 43.06 |
| 02:45 ET | 100 | 43.07 |
| 02:47 ET | 163 | 43 |
| 02:51 ET | 100 | 42.96 |
| 02:56 ET | 1467 | 43.03 |
| 02:58 ET | 400 | 43.035 |
| 03:00 ET | 800 | 43 |
| 03:02 ET | 400 | 43.04 |
| 03:03 ET | 1000 | 43.13 |
| 03:05 ET | 200 | 43.155 |
| 03:09 ET | 500 | 43.115 |
| 03:14 ET | 200 | 43.12 |
| 03:16 ET | 100 | 43.18 |
| 03:18 ET | 137 | 43.1799 |
| 03:20 ET | 200 | 43.21 |
| 03:21 ET | 100 | 43.21 |
| 03:25 ET | 1852 | 43.39 |
| 03:27 ET | 13133 | 43.6 |
| 03:30 ET | 400 | 43.65 |
| 03:32 ET | 400 | 43.7 |
| 03:34 ET | 1100 | 43.73 |
| 03:36 ET | 400 | 43.72 |
| 03:38 ET | 1732 | 43.67 |
| 03:39 ET | 800 | 43.71 |
| 03:41 ET | 641 | 43.7 |
| 03:43 ET | 2676 | 43.475 |
| 03:45 ET | 1276 | 43.47 |
| 03:48 ET | 2928 | 43.53 |
| 03:50 ET | 743 | 43.525 |
| 03:52 ET | 1736 | 43.525 |
| 03:54 ET | 1822 | 43.435 |
| 03:56 ET | 2032 | 43.54 |
| 03:57 ET | 2381 | 43.53 |
| 03:59 ET | 89193 | 43.73 |
Today
Xenon to Report Q2 2024 Financial Results on August 8, 2024, from 5 hours ago by Dow Jones
5 hours ago by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Xenon Pharmaceuticals Inc | 3.2B | -16.1x | --- |
Biohaven Ltd | 3.4B | -5.6x | --- |
Vitaspring Biomedical Co. Ltd | 3.1B | 3,311.3x | --- |
Morphic Holding Inc | 2.9B | -15.3x | --- |
Immunitybio Inc | 3.7B | -4.5x | --- |
Apogee Therapeutics Inc | 2.8B | -22.4x | --- |
Company Information
Xenon Pharmaceuticals Inc. is a Canada-based clinical-stage biopharmaceutical company focused on developing therapeutics to improve the lives of patients with neurological disorders, with a focus on epilepsy. The Company’s product pipeline includes XEN1101 (Focal Onset Seizures), XEN1101 (Primary Generalized Tonic-Clonic Seizures), XEN1101 (Major Depressive Disorder) and NBI-921352 (NEUROCRINE). It is developing XEN1101, a differentiated Kv7 potassium channel opener, for the treatment of epilepsy, MDD and potentially other neurological disorders. Its XEN1101 Phase III epilepsy program includes two identical Phase III clinical trials, called X-TOLE2 and X-TOLE3, that are designed closely after the Phase IIb X-TOLE clinical trial. Its Phase III X-ACKT clinical trial is intended to support potential regulatory submissions in an additional epilepsy indication of primary generalized tonic-clonic seizures (PGTCS).
Contact Information
- Headquarters
- 3650 Gilmore WayVANCOUVER, BC, Canada V5G 4W8
- Phone
- 604-484-3300
- Fax
- 604-484-3450
Executives
- President, Chief Executive Officer, Director
- Ian Mortimer
- Chief Financial Officer
- Sherry Aulin
- Executive Vice President - Drug Discovery
- James Empfield
- Executive Vice President - Strategy and Innovation
- Robin Sherrington
- Chief Medical Officer
- Christopher Kenney
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.2B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 75.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.26 |
EPS | $-2.71 |
Book Value | $12.31 |
P/E Ratio | -16.1x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
